Keyword Suggestion
Domain Informations
Unicycive.com lookup results from whois.godaddy.com server:
- Domain created: 2016-08-14T13:50:42Z
- Domain updated: 2024-08-09T22:53:33Z
- Domain expires: 2027-08-14T13:50:42Z 2 Years, 330 Days left
- Website age: 8 Years, 34 Days
- Registrar Domain ID: 2052175227_DOMAIN_COM-VRSN
- Registrar Url: http://www.godaddy.com
- Registrar WHOIS Server: whois.godaddy.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 480-624-2505
- Name server:
- NS1.BLUEHOST.COM
- NS2.BLUEHOST.COM
Network
- inetnum : 141.193.213.0 - 141.193.213.255
- name : WPENG
- handle : NET-141-193-213-0-1
- status : Direct Allocation
- created : 2020-03-20
- changed : 2020-07-14
Owner
- organization : WPEngine, Inc.
- handle : WPENG
- address : Array,Austin,TX,78701,US
Abuse
- handle : ABUSE7875-ARIN
- name : Abuse
- phone : +1-512-273-3906
- email : [email protected]
Technical support
- handle : ADMIN7400-ARIN
- name : Admin
- phone : +1-877-973-6446
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 141.193.213.10)
Spam Check (IP: 141.193.213.10)
Email address with unicycive.com
2. [email protected]
3. [email protected]
4. [email protected]
Recent Searched Sites
› Unicycive.com (1 seconds ago) / US
› Vpr.hkma.gov.hk (8 seconds ago) / SG
› Openkochi.net (15 seconds ago) / US
› Nou-uspeh.ru (4 seconds ago) / RU
› Nasusare.jp (7 seconds ago) / JP
› Kazaarfragrances.com (9 seconds ago) / CA
› Food2.me (12 seconds ago) / AU
› Macsx.com (3 seconds ago) / US
› Mns.udsu.ru (5 seconds ago) / RU
› Kinovibe.co (12 seconds ago) / US
› Library.lmunet.edu (21 seconds ago) / US
› Wallinvogue.com (5 seconds ago) / CA
› Bdg-game.org.in (18 seconds ago) / DE
› Getmosh.com.au (26 seconds ago) / US
› Ec2-52-21-113-188.compute-1.amazonaws.com (2 seconds ago) / US
› Webpo.jp (17 seconds ago) / US
› Birdsallmarine.com (26 seconds ago) / US
› 104.26.15.149 (4 seconds ago) / US
› Strykerneurovascular.com (16 seconds ago) / US
› Hemis.bsmi.uz (3 seconds ago) / UZ
Websites Listing
We found Websites Listing below when search with unicycive.com on Search Engine
Unicycive
Unicycive Therapeutics is passionate about treating kidney diseases with significant unmet medical needs. Go to page. Therapeutic Focus. Kidney disease remains a major global health issue and Unicycive is committed to …
Unicycive.comCompany - Unicycive
Dr. Shalabh Gupta, MD, founder, chairman of the board of directors and CEO of Unicycive Therapeutics Inc. Read full bio. John Townsend. CPA. Mr. John Townsend, CPA, Chief Financial Officer at Unicycive Therapeutics Inc. Read full bio. Douglas Jermasek. MBA. Douglas Jermasek joined Unicycive in 2021 as Executive Vice President, Corporate Strategy. Read full bio . …
Unicycive.comUnicycive Therapeutics Inc Email Formats & Employee Phones ...
Contact and general information about Unicycive Therapeutics Inc company, headquarter location in Los Altos, CA. Email formats & phone numbers of Unicycive Therapeutics Inc 10-50 employees. Biotechnology
Signalhire.comUnicycive to Present at Upcoming March Investor Conferences
2022-03-03 · For questions or further information about Unicycive, please contact Anne Marie Fields of Stern IR at 212-362-1200 or submit your request to [email protected]. Maxim Group 2nd Annual Virtual ...
Prnewswire.com(UNCY) - Maxim Group Initiates Coverage On Unicycive ...
1 hour ago · Maxim Group Initiates Coverage On Unicycive Therapeutics with Buy Rating, Announces Price Target of $3. Benzinga Newdesk, Benzinga Staff Writer {{following ? "Following" : "Follow"}} March 16 ...
Benzinga.comUnicycive to Present at Upcoming March Investor ...
2022-03-03 · To schedule a one-on-one meeting with Unicycive, please contact your ROTH representative. For questions or further information about Unicycive, please contact Anne Marie Fields of Stern IR at 212-362-1200 or submit your request to [email protected]. Maxim Group 2nd Annual Virtual Growth Conference. Date/Time: March 28, 2022 at 1:00 pm Eastern time.
Biospace.comUnicycive Therapeutics - Crunchbase Company Profile & Funding
1 email found 1 phone number found . View contacts for Unicycive Therapeutics to access new leads and connect with decision-makers. View All Contacts . Details. Industries . Biotechnology. Health Care. Health Diagnostics. Medical. Headquarters Regions San Francisco Bay Area, Silicon Valley, West Coast; Founded Date 2016; Founders Shalabh Gupta; Operating Status Active; …
Crunchbase.comUnicycive Therapeutics’s Profile | User Walls Journalist ...
By Brii Biosciences Limited, Unicycive Therapeutics, TB Alliance. | User Walls. MONTREAL, Nov. 5, 2021 /CNW Telbec/ - Laurentian Organic Inc. (LO or the Company) is pleased to announce that Mr. Justin Kausel has been appointed Vice President of Business Development. Justin brings a deep wealth of knowledge from his previous senior executive ...
Muckrack.comUnicycive Therapeutics Information | Unicycive ...
Before RocketReach, the process of sourcing email addresses consisted of scouring the internet, asking mutual friends, or stalking on LinkedIn. The most frustrating part was how time consuming this all was.The first time I used RocketReach was when I realized I made the right decision. Finding emails for contacts turned into a one-and-done instead of a week long process.
Rocketreach.coUnicycive Therapeutics, Inc. (NASDAQ:UNCY) Short Interest ...
2022-03-05 · Unicycive Therapeutics, Inc. (NASDAQ:UNCY – Get Rating) saw a significant increase in short interest in the month of February. As of February 15th, there was short interest totalling 119,600 ...
Etfdailynews.comUnicycive Therapeutics Inc. (UNCY): Up ahead of its ...
2022-01-26 · Unicycive Therapeutics Inc. (UNCY) is priced at $1.83 after the most recent trading session. At the very opening of the session, the stock price was $1.66 and reached a high price of $1.81, prior to closing the session it reached the value of $1.80. The stock touched a low price of $1.6239.Recently
Investchronicle.comUnicycive Therapeutics Inc - UNCY Stock News | StockTitan.net
2021-11-29 · Unicycive Therapeutics Announces Third Quarter 2021 Financial Results. Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical stage biotechnology company developing therapies for patients with kidney disease, today reported financial results for the third quarter ended September 30, 2021.Shalabh Gupta, M.D., Chief. RHEA-AI.
Stocktitan.netUnicycive Therapeutics Stock Forecast, Price & News ...
2022-03-07 · Unicycive Therapeutics' lock-up period expired on Monday, January 10th. Unicycive Therapeutics had issued 5,000,000 shares in its IPO on July 13th. The total size of the offering was $25,000,000 based on an initial share price of $5.00. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a ...
Marketbeat.comUNCY - Unicycive Therapeutics Inc. • BioPharmCatalyst
Unicycive's lead product candidate, Renazorb, is a novel phosphate binding agent being developed for the treatment of hyperphosphatemia. UNI-494 is a patent-protected new chemical entity in late preclinical development for the treatment of acute kidney injury. For more information, please visit www.unicycive.com. Contacts: [email protected]
Biopharmcatalyst.comMicro-cap kidney disease biotech Unicycive Therapeutics ...
2021-07-13 · Unicycive Therapeutics, an early-stage biotech developing in-licensed therapies for kidney disease, raised $25 million by offering 5 million units …
Nasdaq.comUnicycive Therapeutics to Present at the H.C. Wainwright ...
2022-01-10 · Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh Gupta, M.D., Chief Executive ...
Finance.yahoo.comUnicycive Therapeutics Receives Confirmatory Guidance on ...
2021-11-29 · Unicycive's lead product candidate, Renazorb, is a novel phosphate binding agent being developed for the treatment of hyperphosphatemia. UNI-494 is a patent-protected new chemical entity in late ...
Finance.yahoo.comUnicycive Therapeutics, Inc. (UNCY) Company Profile ...
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los ...
Ca.finance.yahoo.comUnicycive Therapeutics - VentureRadar
Unicycive Therapeutics is passionate about treating kidney diseases with significant unmet medical needs. Our development programs are focused on three kidney diseases: (1) Hyperphosphatemia; a medically significant condition in patients with Chronic Kidney Disease, (2) Acute Kidney Disease and (3) Gitelman Syndrome. Research has linked these three diseases …
Ventureradar.comUnicycive Therapeutics, Inc. (UNCY) Options Chain - Yahoo ...
View the basic UNCY option chain and compare options of Unicycive Therapeutics, Inc. on Yahoo Finance.
Ca.finance.yahoo.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| lovetop5.com | namecheap.com | -2 Years, -177 Days |
| soc-usa.com | godaddy.com | -1 Years, -254 Days |
| shbet.org | namecheap.com | -1 Years, -348 Days |
| sante-clean.com | namecheap.com | -1 Years, -247 Days |
| mawdoo3.io | namecheap.com | -2 Years, -1 Days |
| transindgroup.com | godaddy.com | -1 Years, -254 Days |
| antizionistleague.com | namebright.com | -2 Years, -143 Days |
| weoxe.com | namecheap.com | -1 Years, -293 Days |
| trondheim.com | realtimeregister.com | -2 Years, -21 Days |
| icamur.org | interdominios.com | -2 Years, -99 Days |